Thursday, December 13, 2007

Azithromycin 600-mg tablets

On Nov. 14, the FDA approved first-time wine formulations of cefprozil 250- and 500-mg tablets (made by Sandoz, Inc; mark name Cefzil, made by Bristol-Myers Squibb),

Cefprozil tablets are indicated for the human action of mild to moderate pharyngitis/tonsillitis, otitis media, acute sinusitis, coil bacterial infections of acute bronchitis, acute bacterial exacerbations of chronic bronchitis, and uncomplicated skin/skin noesis infections caused by susceptible strains of microorganisms.
Merchandise wine Azithromycin 250-, 500-, and 600-mg Tablets (Zithromax) for Indicated Infections

On Nov. 14, the FDA approved first-time wine formulations of azithromycin 250-, 500-, and 600-mg tablets (made by Teva Pharmaceuticals USA and Sandoz, Inc; marque name Zithromax, made by Pfizer, Inc).
Azithromycin tablets are indicated for the administration of adults with mild to moderate infections caused by susceptible strains of designated microorganisms.
Drug indications for the 250-and 500-mg in adults include acute bacterial exacerbations of chronic obstructive pulmonary disease, acute bacterial sinusitis, community-acquired pneumonia (CAP), pharyngitis/tonsillitis, uncomplicated skin/skin construction body part infections, urethritis, cervicitis, and genital ulcer disease (men only).
The tablets may also be used to provender acute otitis media, CAP, and pharyngitis/tonsillitis in pediatric patients.

Azithromycin 600-mg tablets are indicated for the aid of acute bacterial exacerbations of chronic obstructive pulmonary disease, CAP, pharyngitis/tonsillitis, uncomplicated skin/skin artefact infections, and non-gonococcal urethritis/cervicitis.
They are also indicated for the prophylaxis and faculty of disseminated Mycobacterium avium intuitive feeling (MAC) disease.
This is a part of article Azithromycin 600-mg tablets Taken from "Azithromycin Zithromax" Information Blog

No comments: